“The telehealth means I get distance from the hospital so I don’t feel so much like a patient”: A qualitative sub-study examining the acceptability of nurse-led follow-up for ovarian cancer via telehealth using the MOST-S26 to structure consultations.Rachel Campbell, Paul A. Cohen, Megan S Jeon et al.|Journal of Clinical Oncology|2025Cited by 0
REPURPOSE: PHASE II STUDY ASSESSING THE EFFICACY OF EFAVIRENZ, AN APPROVED HIV DRUG REPURPOSED AS AN ANTI-CANCER AGENT, IN PATIENTS WITH PLATINUM RESISTANT OVARIAN CANCERJanine Lombard, Nikola A. Bowden, Gaik Tin Quah et al.|International Journal of Gynecological Cancer|2025Cited by 0